Rate My Professor Dean Pountney
Ratings & reviews
Encourages students to think outside the box.
Makes complex topics easy to understand.
Always supportive and understanding.
Always fair, constructive, and supportive.
Taught by or worked with Dean?
Add your rating. It takes about 30 seconds.
About Dean
Dr. Dean Pountney is a Senior Lecturer in the School of Medical Science within Griffith Health at Griffith University, serving as Discipline Lead in Biochemistry and Group Leader of the Neurodegeneration Research Group. He earned his PhD in Biochemistry from the University of East Anglia in 1992 and a first-class BSc (Hons) in Chemistry from Kingston University in 1988. He holds the status of Chartered Chemist from the Royal Society of Chemistry (UK, 1992). Pountney's distinguished career includes early positions as Research Fellow and Teaching Assistant at the University of Zurich (1990–1995), Research Associate at the University of Adelaide (1995–1997), Senior Research Associate at the University of Minnesota (1997–1998), Scientist at CSIRO in Adelaide (1998–2000), and Senior Research Officer/Lecturer at Flinders University (2000–2004). Since joining Griffith University in 2005 as Lecturer, he has progressed to Senior Lecturer, contributing significantly to biochemistry and neuroscience education and research.
His research focuses on the biochemistry of neurodegeneration, particularly Parkinson's disease and alpha-synucleinopathies, investigating alpha-synuclein aggregation, metal homeostasis (iron, copper), metallothioneins, calcium regulation, tunnelling nanotubes, glymphatic clearance, and therapeutic strategies including autophagy modulation and exercise mechanisms. Pountney has authored over 50 publications, with more than 3,300 citations. Key works include 'Epothilone D Inhibits Microglia-Mediated Spread of Alpha-Synuclein Aggregation' (Molecular and Cellular Neuroscience, 2018), 'Chemistry of Mammalian Metallothioneins and their Interaction with Amyloidogenic Peptides and Proteins' (Chemical Society Reviews, 2017), 'Therapeutic Mechanisms of Exercise in Parkinson’s Disease' (2025), and 'Potassium Channels in Parkinson’s Disease: Potential Roles in Its Pathogenesis and Innovative Molecular Targets for Treatment' (2023). He has secured competitive funding from the Australian NHMRC (e.g., project grants APP1027628, 2012–2014; APP1084386, 2015–2017) and Griffith University. Pountney serves on the editorial board of Neuroscience Letters, has guest-edited special issues on synucleinopathies, and delivered invited lectures on neurodegeneration topics such as iron accumulation in Parkinson's disease.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash